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The role of chemokines and their receptors in HIV biology and Kaposi’s sarcoma (KS) pathogenesis has recently gained considerable
attention. It has been shown that KS-associated human herpes virus type 8 (KSHV/HHV-8) encodes functional homologues of certain
chemokines and chemokine receptors. This suggests that chemokines may contribute to the growth and spread of KS seen in AIDS. We
found the expression of CXCR4 in primary KS tissue by using in situ hybridization (ISH). Recently, alpha-chemokine receptors CXCR1
and CXCR2 have also been shown to be expressed by KS tissues. We further characterized the expression of these chemokines as well as
the signaling events induced upon binding to their respective cognate ligands in the KS 38 spindle cell line. These cells express authentic
characteristics of primary KS spindle cells and provide a useful in vitro model for these studies. We observed using RT-PCR that KS 38
cells express mRNA for the alpha-chemokine receptors CXCR1, CXCR2, and CXCR4. We also confirmed the cell surface protein
expression by FACS analysis. Characterization of signaling pathways revealed that the alpha-chemokines, IL-8 and stromal cell-derived
factor 1a (SDF1a/CXCL12), activated members of the mitogen-activated protein (MAP) kinase family, including Erk kinase, c-Jun amino
terminal kinase (JNK)/stress-activated protein kinase (SAPK) and the p38 MAP kinase. Furthermore, using DNA protein-binding
experiments, we have shown that IL-8 increased AP-1 and NF Kappa B activity in these cells. IL-8 also enhanced the chemotaxis of KS
cells. These results reveal that chemokine-induced signaling pathways may mediate cell growth, transcriptional activation and cell
migration in KS.
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There is a growing body of data suggesting that chemo-
kines may play an important role in the pathogenesis of
Kaposi’s sarcoma (KS) [1–3]. The KS herpes virus (KSHV)/
human herpes virus 8 (HHV-8), a candidate etiological agent
for this tumor, encodes an activated interleukin-8 (IL-8)
receptor as well as a protein with close homology to
macrophage inflammatory protein 1 (MIP-1) [4–9]. In
addition, HIV infection of monocytes-macrophages and T-
cells results in the release of a variety of soluble mediators,
including chemokines that may act in a paracrine fashion to
modulate KS growth and migration [10,11].
There are four recognized classes of chemokines: the C-
X-C or alpha-chemokines; C-C or beta-chemokines; C or
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[12,13], which are grouped according to the array of their
cysteine (C) residues. Chemokine receptors contain seven
transmembrane domains and are functionally linked to
phospholipases via heterotrimeric G proteins [12,13]. Che-
mokine receptor activation leads to downstream generation
of inositol triphosphate, resulting in intracellular calcium
release and protein kinase C activation [14,15]. Chemokines
have also been shown to activate focal adhesion components
and tyrosine phosphatases [16,17].
Alpha-chemokine receptors CXCR1 and CXCR2 have
been shown to be expressed in primary tumor tissue and KS
cells [3]. The levels of IL-8, the cognate ligand of CXCR1
and CXCR2, are also elevated in KS patients. Furthermore,
IL-8 has been shown to induce growth in KS cells [3].
KSHV/HHV-8 encodes a GPCR that is homologous to the
IL-8 receptor [4,18,19]. Recently, the alpha-chemokine
receptor CXCR4 was shown to be expressed by the IL-
1h-stimulated KS cell line, KS-Y1 [20]. CXCR4 has also
been observed to play an important role in the metastasis of
various cancer cells [21,22]. Intriguingly, CXCR4 can also
act as a co-receptor for the HIV species [12].
Despite the increasingly prominent role of chemokines
and chemokine receptors in the biology of HIV and KS,
relatively little is characterized about the signal transduction
pathways downstream of these G protein-linked receptors in
KS cells. In this study, we have focused on the expression of
chemokines by KS spindle cells in vivo and characterization
of their downstream signaling pathways in vitro. Our results
indicate that KS spindle cells express alpha-chemokine
receptors, which induce a distinct set of intracellular signal-
ing molecules in response to cognate ligand stimulation.2. Materials and methods
2.1. Cells and cell culture
The human KS cell line, KS 38, derived from a biopsy of
a cutaneous lesion from an AIDS patient, has been previ-
ously characterized as a model for signal transduction
studies [23]. This KS cell line expresses many of the
characteristics of primary spindle cells including endothelial
and smooth muscle markers and is monoclonal in origin
[24]. KS 38 cells were grown on 1.5% gelatin-coated flasks
and carried in RPMI-1640 medium with 15% fetal calf
serum (FCS), 2 mM glutamine, 1 mM MEM sodium
pyruvate, 0.05 mM MEM nonessential amino acids, 1
MEM amino acids, 1% nutridoma-HU (Boehringer Man-
nheim, Indianapolis, IN) and 50 Ag/ml penicillin and 50 Ag/
ml streptomycin. Cultures were grown until near confluence
prior to the different treatments in the signaling studies
described below [23]. The human CXCR1, CXCR2, and
CXCR4 receptors transfected into the L1.2 cell line (a
murine pre B lymphoma cell line) were generously provided
by LeukoSite, Inc. (Cambridge, MA), and maintained inRPMI-1640 medium supplemented with 10% FCS and 800
Ag/ml G418. The KSHV-positive, BCBL-1, and the KSHV-
negative cell line, BJAB, were cultured in RPMI-1640
medium supplemented with 10% fetal bovine serum, pen-
icillin, streptomycin, glutamine, and sodium bicarbonate.
2.2. Reagents and antibodies
Anti-CXCR1 and CXCR2 monoclonal antibodies were
generous gifts from LeukoSite. The anti-phosphotyrosine
monoclonal antibody (4G10) was generously provided by
Dr. Brian Druker, Oregon University. p38, Erk-1, Erk-2 and
JNK antibodies as well as the recombinant GST-c-Jun NH2-
protein (1–79 amino acids) were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). The substrate myelin
basic protein (MBP) was obtained from Upstate Biotech-
nology, Inc. (Lake Placid, NY). Horseradish peroxidase
(HRP)-conjugated sheep anti-mouse immunoglobulin
(IgG) was purchased from Amersham Corp. (Arlington
Heights, IL). Electrophoresis reagents were obtained from
Bio-Rad Laboratories (Hercules, CA). The protease inhib-
itors leupeptin, aprotinin and alpha 1 antitrypsin and all
other chemical reagents were obtained from Sigma Chem-
ical (St. Louis, MO). Recombinant human CXCL12, IL-8,
and anti-CXCR4 antibodies were purchased from R&D
Systems (Minneapolis, MN). For the transcription factor
studies, the AP-1 and NF Kappa B gel shift oligonucleotides
were purchased from Santa Cruz Biotechnology.
2.3. Stimulation of cells
KS 38 cells, grown to 80% confluence, were serum-
starved for 16–18 h and washed twice with Hanks balanced
salt solution (Gibco BRL, Gaithersburg, MD) prior to
chemokine treatments. After initial studies to determine
optimal dose and time of treatment, we performed subse-
quent experiments using a concentration of 20 nM IL-8 and
CXCL12. After stimulation, cell lysates were directly pre-
pared within the culture dish by lysis in 500-Al modified
RIPA buffer (50 mM Tris–HCl, pH 7.4, 1% NP-40, 0.25%
sodium deoxycholate, 150 mM NaCl, 1 mM PMSF, 10 Ag/
ml of aprotinin, leupeptin and pepstatin, 10 mM sodium
vanadate, 10 mM sodium fluoride and 10 mM sodium
pyrophosphate) per dish at varying time points. Total cell
lysates (TCL) were clarified by centrifugation at 13,000 g
for 10 min. Protein concentrations were determined by
protein assay (Bio-Rad Laboratories).
2.4. RT-PCR analysis
Total RNA was extracted from KS 38 cells using the
ULTRASPEC-II RNA isolation system (Biotecx Laborato-
ries, Houston, TX). Two micrograms of total RNA was
denatured by heating and reverse transcribed with 20 U
Moloney Murine Leukemia Virus (MMLV) Reverse Tran-
scriptase into first strand cDNA using 30 pmol of primers
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Al final volume containing 5 mM DTT, 40 U RNAsin, 5
mM dNTP mixture, and 5 buffer (200 mM Tris, pH 8.3,
40 AM MgCl2). PCR was performed in a DNA thermalFig. 1. Expression of chemokines and chemokine receptors in KS 38 cells using RT
used for cDNA synthesis using MMLV reverse transcriptase. A quarter of this re
polymerase (Perkin-Elmer). Specific primers were used to amplify CXCR1 (a), C
electrophoresed through a 2% agarose gel. Size markers (MW) used were the 12
expression, total cellular RNA from TrHBMEC was used as a positive control; for
was used as a positive control. (B) KS 38 cells (5 105) were stained with isot
monoclonal antibody followed by FITC-conjugated affinity-purified F(abV)2 goa
cytometer, as described in Materials and methods. The staining with control antib
antibody against each receptor is represented by the line shifted to the right in each
were used as a positive control and mouse IgG was used as a negative control (dat
(negative control) or BCBL-1 (positive control). RT-PCR was performed using spe
described in Materials and methods. The KSHV-GPCR gene construct in pcDNA
analysis.cycler (Perkin-Elmer Cetus Corp., Norwalk, CT) using 5
Al of the transcription mixture and 2.5 U of Taq polymerase.
dNTPs (0.2 mM), 10 reaction buffer (100 mM Tris–HCl,
pH 8.3, 50 mM KCl, 15 mM MgCl2, 0.01% gelatin), and 30-PCR and FACS analysis. (A) Total cellular RNAwas isolated and 2 Ag was
action was used as a template for PCR amplification with AmpliTaq DNA
XCR4 (b), and CXCL12 (SDF-1a) (c). The PCR-amplified fragments were
3-bp and 1-kb DNA ladders (Life Technologies). For CXCR1 or CXCL12
CXCR4 expression, total cellular RNA from CXCR4-transfected L1.2 cells
ype control antibody or with anti-CXCR1 (a), CXCR2 (b) or CXCR4 (c)
t anti-mouse IgG. Immunofluorescence was analyzed by a FACscan flow
ody is represented by the left line in each panel, and the staining with the
panel. L1.2 cells transfected with the CXCR4, CXCR1 or CXCR2 receptor
a not shown). (C) Total cellular RNAwas isolated from KS 38 cells: BJAB
cific primers for KS-GPCR (upper panel) or for beta-actin (lower panel), as
3.1 (pcDNA3.1KS-GPCR) was also used as a positive control for the PCR
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for 30 cycles at 94 jC for 30 s, 55 jC for 30 s and 72 jC for
30 s. The following specific oligomers were used: CXCR1
primers, 5V-AGATCCACAGATGTGGGATTTTGA-3V and
5V-AGAAGTGTAGGAGGTAACACGA-3V; CXCR4 pri-
mers, 5V-GACCGCTACCTGGCCATT-3V and 5V-GT-
TGTAGGGCAGCCAGCA-3V [22] CXCL12 primers,
5V-AAGCCATGTTGCCAGAGC-3V and 5V-TCATGGTT-
AAGGCCCCCT-3V [25].
To detect expression of the KSHV/HHV-8-encoded G
protein-coupled receptor (KSHV-GPCR), total RNA was
isolated from KS 38 cells: BJAB (the negative control) or
BCBL-1 (the positive control). RT-PCR was then performed
using the TITANIUMk One Step RT-PCR kit (BD Bio-
sciences, Palo Alto, CA) according to the manufacturer’s
instructions. The following specific oligomers were used for
the KSHV-GPCR primers, 5V-GGAATTCATGGCGGCC-
GAGGATTTCC-3V and 5V-GTCTAGACGTGGTG-
GCGCCGGACATG-3V. The KSHV-GPCR gene construct
in pcDNA3.1 was also used as a positive control for the PCR
analysis. RT-PCR amplification of the beta-actin gene was
performed as a control using the same kit. The RT-PCR
products were analyzed by 1% agarose gel electrophoresis.
2.5. Western blot analysis
TCL were boiled in 2 sodium dodecyl sulfate (SDS)
sample buffer, and 100 Ag of protein from each lysate was
resolved by SDS-polyacrylamide gel electrophoresis
(PAGE) and then transferred to nitrocellulose membranes.
The membranes were blocked with 5% nonfat milk protein
and probed with primary antibody for 2 h at room temper-Fig. 2. In situ hybridization studies. Brightfield and corresponding dark-field photo
mRNA (A, B). Background levels were low using sense probes as a control (C,ature. Immunoreactive bands were visualized using HRP-
conjugated secondary antibody and the enhanced chemilu-
minescent (ECL) system (Amersham). Immunoreactive
bands were quantitated to determine the relative changes
in phosphorylated proteins by scanning the blot under a
Model GS-700 Imaging Densitometer (Bio-Rad).
2.6. Immunoprecipitation
For the immunoprecipitation studies, identical amounts
of protein from each sample were clarified by incubation
with protein A-Sepharose CL-4B (Pharmacia Biotech, Pis-
cataway, NJ) for 1 h at 4 jC. Following the removal of the
protein A-Sepharose by brief centrifugation, the solution
was incubated with different primary antibodies as detailed
below for each experiment for 4 h or overnight at 4 jC. The
immunoprecipitations of the antibody–antigen complexes
were performed by incubation for 2 h at 4 jC with 75 Al of
the protein A-Sepharose (10% suspension). Nonspecific
bound proteins were removed by washing the Sepharose
beads twice with the modified RIPA buffer and twice with
kinase buffer.
2.7. JNK kinase assay
Cell lysates were immunoprecipitated with JNK antibody
(Santa Cruz Biotechnology). The immune complexes were
washed twice with RIPA buffer and twice in kinase buffer
(50 mM HEPES, pH 7.4, 10 mM MgCl2, 20 AM ATP). The
complex was then incubated in kinase buffer containing
recombinant GST c-Jun 0.2 Ag/Al (1–79 amino acids) (Santa
Cruz Biotechnology) and 5 ACi g32P-ATP for 30 min at roommicrographs showing strong labeling of KS cells for expression of CXCR4
D). Bar = 50 Am.
Fig. 3. Tyrosine phosphorylation of cellular proteins in KS 38 cells after
chemokine stimulation. Serum-starved KS 38 cells were stimulated with the
specified chemokines for the indicated times. One hundred micrograms of
total cell lysates (TCL) prepared from unstimulated (UN) or stimulated cells
was separated on 10% SDS-PAGE, transferred to nitrocellulose membranes
and probed with anti-phosphotyrosine (4G10) antibody. The arrows
indicate the proteins in which the tyrosine phosphorylation is increased
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SDS sample buffer and boiling the sample for 5 min at 100
jC. Proteins were separated on 12% SDS-PAGE and
detected by autoradiography. The phosphorylated bands of
GST c-Jun, the substrate for JNK, were quantitated by
scanning the blot under a Model GS-700 Imaging Densi-
tometer (Bio-Rad). Rabbit IgG was used as a negative
control.
2.8. FACS analysis
KS 38 cells were harvested using a rubber policeman.
Viable cell counts were determined by the trypan blue dye
exclusion method. After washing with PBS, cells were
resuspended in 100-Al PBS containing 2% FCS and incu-
bated for 30 min at 4 jC. Purified mouse monoclonal
antibody (5 Ag/ml) against CXCR1, CXCR2, or CXCR4,
or isotype control mouse IgG, was added. After 1-h incuba-
tion at 4 jC, cells were washed twice with cold PBS, and
were then incubated with 100-Al FITC-conjugated affinity-
purified F(abV)2 goat anti-mouse IgG for 30 min at 4 jC.
After washing, cells were resuspended in 500 Al of PBS and
analyzed with a FACscan flow cytometer (Becton Dick-
inson, San Jose, CA) to determine the level of surface
expression of these receptors. Specificity of the antibody
against CXCR1, CXCR2 or CXCR4 was confirmed by flow
cytometry using the CXCR1-, CXCR2-, or CXCR4-trans-
fected L1.2 cell line, respectively.
2.9. In situ hybridization studies (ISH)
Four-micron-thick frozen sections of KS were derived
from six patients. ISH studies were performed with anti-
sense probes for CXCR4 and with sense probes as a control.
Details of ISH have been published previously [26].
Briefly, slides were passed through 0.2% glycine; 4% para-
formaldehyde in PBS, pH 7.4; 0.1 M triethanolamine con-
taining 1/200 (vol/vol) acetic anhydride; and 2 SSC. Slides
were hybridized overnight at 50 jC with 35S-labeled ribonu-
cleotide probes in the following mixture: 0.3MNaCl, 0.01M
Tris, pH 7.6, 5 mM EDTA, 50% formamide, 10% dextran
sulfate, 0.1 mg/ml yeast tRNA, and 0.01 M dithiothreitol.
Post-hybridization washes included 2 SSC/50% formam-
ide/10 mM dithiothreitol at 50 jC; 4 SSC/10 mM Tris/1
mM EDTA with 20 Ag/ml ribonuclease at 37 jC; and 2
SSC/50% formamide/10 mM dithiothreitol at 65 jC and 2
SSC. Slides were then dehydrated through graded alcohol
containing 0.3 M ammonium acetate, dried, coated with
Kodak NTB 2 emulsion and stored in the dark at 4 jC for 2
weeks. The emulsion was developed with Kodak D19 devel-
oper and the slides were counterstained with hematoxylin.
2.10. Isolation of nuclear proteins
Cells were serum-starved in a 37 jC incubator for 4 h,
followed by 30 min of mock or chemokine treatment.Nuclear proteins were then isolated using standard meth-
ods [27]. The protease inhibitors antipain (1 Ag/ml),
leupeptin (1 Ag/ml), phenylmethylsulfonyl fluoride (0.1
mM) and the phosphatase inhibitor Na3VO4 (1 mM) were
added to all buffers except the dialysis buffer. Dithiothrei-
tol (1 mM) was added to all buffers. After dialysis, the
protein concentrations were determined using an assay kit
(Bio-Rad), and aliquots of the proteins were stored at
 80 jC.
2.11. Electrophoretic mobility shift assay (EMSA)
Double-stranded oligonucleotides containing the consen-
sus binding site for AP-1 (5V-CGC TTG ATG ACT CAG
CCG GAA-3V) o r NF Kappa B (5V-AGT TGA
GGG GAC TTT CCC AGG C-3V) were labeled with g32P-
ATP (3,000 Ci/mmol, DuPont NEN, Boston, MA) using
polynucleotide kinase (Promega, Madison, WI) according
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was incubated with 10 Ag of nuclear proteins (as specified in
Results) for 10 min at room temperature in the presence of
250 ng of poly d(I)–d(C) oligomer (Boehringer Mannheim)
and DNA-binding buffer as described previously [28]. The
complexes were then separated on a 7.5% polyacrylamide gel
and autoradiographed. The results shown in each of the
figures are representative of findings from at least three
independent experiments.Fig. 4. Chemokines activate various MAP kinases in KS 38 cells. KS 38 cells, unst
cell lysates (TCL) prepared from each sample was resolved by 12% SDS-PAGE
immunoblotted with anti-phospho-Erk antibody (P-Erk, top panel) followed by E
stimulated with CXCL12 or IL-8, were immunoprecipitated with anti-JNK antibody
were subjected to in vitro kinase assay using GST-c-Jun as a substrate for 30 min
autoradiography. (C) One hundred micrograms of TCL prepared from cells, unstim
SDS-PAGE and then transferred to nitrocellulose membranes. The membranes
followed by p38 antibody (bottom panel). For quantitative analysis of protein pho
obtained by densitometry. The phosphorylation index shown in the bar graph for
each lane and presenting the ratios as the fold increase over the control value (the
index shown in the graph of panel B represents the relative densitometry valu
unstimulated sample (UN), which was taken as a value of 1.2.12. Chemotaxis assays
Migration assays were performed using 5-Am pore
filters (Transwell, 24-well cell clusters; Costar, Boston,
MA). The lower side of each filter was coated with 1%
gelatin for 10 min at room temperature. The filters were
blocked with PBS containing 1% BSA for 1 h at 37 jC
and then were equilibrated in migration medium (RPMI-
1640 with 0.5% BSA). Cells (about 80% confluent) were
ysica Acta 1691 (2004) 129–139imulated or stimulated with CXCL12 or IL-8, were lysed and 100 Ag of total
and then transferred to nitrocellulose membranes. The membranes were
rk antibody (bottom panel). (B) KS 38 cell lysates (1 mg), unstimulated or
. Normal rabbit IgG was used as a negative control. The immune complexes
. The reaction products were resolved on 12% SDS-PAGE and detected by
ulated or stimulated with the indicated chemokines, was resolved by 12%
were immunoblotted with anti-phospho-p38 antibody (P-p38, top panel),
sphorylation, the ratio of phosphorylation vs. total protein in each lane was
Erk (A) or p38 (C) was determined by calculating the value of this ratio in
unstimulated sample; 0), which was designated as 1. The phosphorylation
e of GST-c-Jun (the substrate for JNK) in each lane as compared to the
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Cells were washed two times with migration medium and
then loaded into the upper chamber of the inserts
(2 105 cells/0.1 ml migration medium). The inserts
were then carefully transferred to another well containing
650 Al of migration medium with various concentrations
of IL-8 (R&D Systems). The plates were incubated at 37
jC in 5% CO2 for 3 h. Non-migrated cells were
removed from the upper chambers by wiping the upper
surface with a cotton-tip applicator, and the migrated
cells on the under surface were fixed and stained with
the Diff-QuikR stain Kit (Baxter Healthcare, McGaw
Park, IL). The number of migrated cells was counted in
10 randomly selected high power ( 200) fields per
insert. No cells were found in the lower chambers where
the inserts were placed. Each experimental point was
studied in triplicate.Fig. 5. IL-8 and CXCL12 induce AP-1 and NF Kappa B activities in KS 38 cel
(control) or active IL-8 or CXCL12 treatments were incubated with the 32P-labeled
binding buffer for 10 min at room temperature. Incubation was followed by separa
A and B indicates the position of the free probe (no proteins). The arrows indic
Lipopolysaccharide (LPS) was used as a positive control for NF Kappa B (B).3. Results
3.1. Expression of chemokines and chemokine receptors
Total cellular RNA isolated from KS 38 cells was
analyzed by RT-PCR for expression of the chemokine
receptors CXCR1 and CXCR4 and the alpha-chemokine
CXCL12. For CXCR1 or CXCL12, total cellular RNA from
bone marrow endothelial cells (TrHBMEC) was used as a
positive control [25]. For CXCR4, total cellular RNA
isolated from murine B lymphoma L1.2 cells transfected
with the human CXCR4 receptor was used as the positive
control. As shown in Fig. 1A(a–c), there was specific
expression of these receptors and ligand as demonstrated
by RT-PCR. To confirm that there was protein expression of
these receptors on KS 38 cells, flow cytometry analysis was
performed using specific monoclonal antibodies. As shownls. Nuclear proteins (10 Ag) prepared from KS 38 cells 30 min after mock
AP-1 (panel A) or NF Kappa B (panel B) sequence in the presence of DNA-
tion on 7.5% SDS-PAGE and analysis via autoradiography. Lane 1 in panels
ate the position of the AP-1 (A) or NF Kappa B (B) protein complexes.
Fig. 6. IL-8 induces the migration of KS 38 cells. Migration assays were
performed in triplicate using 5-Am pore filters (Transwell) as described in
Materials and methods. Cells (2 105) were loaded into the upper chamber
of the inserts. The inserts were applied to the lower chamber containing 650
Al of migration medium with various concentrations of IL-8, and incubated
at 37 jC in 5% CO2 for 3 h. Non-migrated cells were removed from the
upper chambers by wiping the upper surface with a cotton-tip applicator,
and the migrated cells on the under surface were fixed and stained with the
Diff-QuikR stain Kit. The number of migrated cells was counted in 10
randomly selected high power ( 200) fields per insert. No cells were
found in the lower chambers where the inserts were placed. Each
experimental point was studied in triplicate.
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CXCR1, CXCR2, and CXCR4 receptors on KS 38 cells as
detected by FACS analysis.
KSHV/HHV-8-encoded GPCR (KSHV-GPCR) is ho-
mologous to the IL-8 receptor [4,18,19]. We thus examined
the expression of KSHV-GPCR in KS 38 cells by RT-PCR.
As a positive control, we used total RNA from the BCBL-1
cell line, which harbors KSHV/HHV-8, and as a negative
control we used total RNA from BJAB, which is-free of this
virus. We were unable to detect the expression of KSHV-
GPCR in the KS 38 cells (Fig. 1C). These data are
consistent with previous findings that KS spindle cell lines
do not harbor KSHV/HHV-8 [29].
In order to further confirm the expression of CXCR4 in
KS lesions, we examined the expression of CXCR4 in punch
biopsy specimens of KS lesions that were obtained from six
patients. ISH studies detected strong expression of CXCR4
mRNA in the KS cells in all cases (Fig. 2A and B). Sense
controls showed no specific labeling, and background levels
were low (Fig. 2C and D). Earlier studies have reported
expression of CXCR1 and CXCR2 on KS lesions [3].
3.2. Chemokine signaling pathways in KS 38 cells
Stimulation of target hematopoietic cells expressing
specific chemokine receptors by their cognate ligands is
known to result in the phosphorylation of a number of
intracellular proteins [15–17]. Thus, we first examined KS
38 cells for changes in phosphorylation in response to
CXCL12 or IL-8. A time course of such chemokine-induced
alterations in tyrosine-phosphorylated proteins is shown in
Fig. 3. These results indicate that the expressed receptors for
these chemokines in KS 38 spindle cells function to transmit
signals downstream via tyrosine phosphorylation.
The p44/p42 (Erk) signal transduction molecules com-
prise a group of important transcriptional activators leading
to NF Kappa B, c-Jun, c-fos and ATF2 induction [30]. As
shown in Fig. 4A (upper panel), there was a potent phos-
phorylation of Erk kinase in response to CXCL12 or IL-8.
Equal amounts of Erk protein were present in each sample
(Fig. 4A, bottom panel).
The c-Jun kinase (JNK) is known to be an important
regulator of transcriptional activation in response to a
number of stimuli including growth factors, ultraviolet light,
osmotic stress, and certain G protein-linked receptors such
as those for bradykinin and chemokines [20–22,25,30–32].
We therefore studied activation of JNK kinase in KS 38
cells in response to CXCL12 or IL-8. As shown in Fig. 4B,
there was a robust and rapid activation of JNK kinase in
response to IL-8 and CXCL12.
To further explore other signaling pathways that are
known to act upstream of transcriptional activators, we exam-
ined p38 MAP kinase in KS 38 cells upon stimulation with
these chemokines. p38MAP kinase is known to signal down-
stream to CHOP, MEF2C and other transcriptional activators
[33,34]. Using specific antibody to phosphorylated p38MAPkinase, we observed potent activation of p38 following
CXCL12 stimulation (Fig. 4C, upper panel). However, IL-
8 treatment only showed a slight increase in p38 phosphor-
ylation at the 1-min time point. Equal amounts of p38 protein
were present in each sample (Fig. 4C, bottom panel).
3.3. IL-8 and CXCL12 modulate AP-1 and NF Kappa B in
KS 38 cells
The transcription factors AP-1 and NF Kappa B are
activated by a number of different cytokines, and both are
directly downstream of the JNK and MEK kinase signal-
ing pathways [35,36]. KSHV-GPCR has also been shown
to activate NF Kappa B [18,19]. To determine whether IL-
8 may modulate these two transcription factors in KS
cells, nuclear proteins were prepared from KS 38 cells
treated with IL-8. The binding activity of these nuclear
proteins to AP-1 and NF Kappa B target sequences was
tested with EMSA. KS 38 cells showed constitutive basal
binding activity of the AP-1 and NF Kappa B sequences
(Fig. 5). Stimulation with IL-8 or CXCL12 markedly
increased the binding activity of both the AP-1 and NF
Kappa B sequences.
3.4. IL-8 induces chemotaxis in KS cells
Chemotactic properties of tumor cells are critical param-
eters for the development of angiogenesis and metastasis
[21,22]. IL-8 has been shown to induce angiogenesis and
chemotaxis in several cancer cells [37–39]. Thus, we
analyzed the IL-8-induced chemotaxis of KS cells. As
shown in Fig. 6, treatment with IL-8 enhanced the migration
J.-F. Wang et al. / Biochimica et Biophysica Acta 1691 (2004) 129–139 137of KS cells in a dose-dependent manner. The maximum
chemotaxis was observed when cells were treated with IL-
8 at 100 ng/ml.4. Discussion
Chemokines of the alpha family are emerging as impor-
tant regulatory molecules in the pathobiology of KS [1–6].
The a-chemokine, IL-8 and its cognate receptors, CXCR1
and CXCR2, are expressed in primary KS tumor tissue [3].
Furthermore, IL-8 antibodies block KS cell growth and IL-
8 levels are enhanced in patients with KS as compared with
the controls [3]. In addition, accruing circumstantial data
support a pathogenetic role for KSHV/HHV-8 in this
neoplasm, both in patients with AIDS and in those with
sporadic cases [5,6,8,9]. The chemokines and activated
chemokine receptor expressed by KSHV/HHV-8 may also
play important roles in the development of this neoplasm
[5,40]. Chemokines are also released from HIV-infected
macrophages and T-cells, suggesting that these mediators
may act in a paracrine fashion to modulate KS spindle cell
growth and spread [11]. However, to date, relatively little is
known about the signaling pathways employed by this
family of mediators within KS spindle cells. The chemokine
receptor CXCR4 has received considerable interest because
it acts as a co-receptor for different HIV strains [12].
In the present study, we observed that spindle cells in KS
lesions express the CXCR4 receptor. CXCR1 and CXCR2
receptors have also been shown to be expressed on KS
lesions [3]. We thus used the KS 38 cell line as a model to
characterize downstream signaling events triggered by IL-
8 and CXCL12. We observed expression of the CXCR1 and
CXCR2 receptors which bind to IL-8, and the CXCR4
receptor which is specific for CXCL12 on KS 38 cells.
IL-8 has been reported as relevant to KS pathogenesis [3].
KS 38 cells have previously proved useful in charting signal
transduction pathways mediated by cytokine growth factors
like interleukin-6, oncostatin M, and the vascular endothe-
lial growth factor (VEGF) [23].
Our results indicate potent activation of three distinct
MAP kinase signaling pathways, JNK, p38 MAP kinase,
and Erk-1/2, in response to treatment with IL-8 and
CXCL12. HHV-8-encoded KSHV-GPCR has also been
shown to activate JNK and p38 MAP kinase pathways
[9]. Prior studies by Faris et al. [31] indicated that MAP
kinases are stimulated in KS spindle cells in response to the
cytokine growth factors IL-6 and OSM. However, a recent
report showed that CXCL12 treatment does not induce Ca
elevation in KS-Y1 cells [20]. The present studies suggest
that alpha-chemokine stimulation can lead to activation of
NF Kappa B and AP-1. These are major transcriptional
activators that control the expression of a variety of imme-
diate early genes [31,41–44]. NF Kappa B activation has
been studied extensively in immunoregulatory and inflam-
matory cells, however, very little is known about its role inKS and its activation by chemokines [18,19,45]. Activated
AP-1 and NF Kappa B have been shown to bind to the
promoter region of various chemokines and thereby regulate
their expression [46–48]. NF Kappa B has also been shown
to be important for the survival of cells. Recently, NF Kappa
B activation by UV radiation and by TNF-a was shown to
suppress signals for apoptosis [49,50]. Furthermore, inhibi-
tion of NF Kappa B induces apoptosis in HHV-8 infected
primary effusion lymphoma cells [51]. HHV-8-encoded
KSHV-GPCR has also been shown to activate NF Kappa
B and AP-1 [18,19,45]. Our data suggest that IL-8 may
amplify signals transduced by the KSHV-encoded G pro-
tein-coupled receptor.
Recently, chemokines have been shown to play an
important role in tumor motility that leads to angiogenesis
and metastasis [21,32,33,52]. In the present investigation,
we have shown that IL-8 enhanced the chemotaxis of KS
cells. IL-8 has been shown to be a master regulator of
migration in melanomas and is also associated with liver
metastasis [37–39,53]. These observations suggest that IL-
8 could be a mediator of the tumor growth, metastasis and
angiogenesis of KS cells.
These results suggest that a-chemokine-mediated signal-
ing pathways may regulate the inflammation and angiopro-
liferation seen in KS lesions. Thus, IL-8, which is elevated
in KS patients, may contribute to the development of KS by
stimulating the expression of inflammatory factors which
are dependent on NF Kappa B and immune cell infiltration
characteristic of KS lesions. It also appears that there may
be shared substrates, activated by diverse growth factors,
cytokines, and chemokines that are released by HIV-1-
infected cells and/or produced by KS spindle cells, as well
as HHV-8-encoded gene products which influence the
growth of this neoplasm. Studies of the differential effects
of inhibitors of these signaling substrates in KS spindle cells
as compared to normal types of endothelium may provide
insights into the development of novel agents for this
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